NEW YORK, July 18, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2025 of $0.22 per Class A ordinary share.
Royalty Pharma Declares Third Quarter 2025 Dividend
Seeking Alpha / 1 hour from now 2 Views
Comments